AB-506 is an orally active inhibitor of HBV replication targeting the viral core protein. AB-506 can bind to HBV core protein, accelerate capsid assembly and inhibit HBV pgRNA encapsidation. AB-506 can be used in chronic hepatitis B (CHB) research[1].
Molecular Weight:
461.85
CAS Number:
[2245020-50-0]
Formula:
C21H18ClF2N5O3
Target:
HBV
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted